Effect of Statins on IgG, IgA and IgM Level in Chronic Hemodialysis Patients

Hormozgan University of Medical Sciences

Status: Completed

Conditions: Chronic Kidney Disease

Treatments: Drug: Lipitor

Study type: Interventional

Funder types: Other

Identifiers

NCT01305317

statins and Immunoglobulins

Details and patient eligibility

About

This is double blind randomized controlled trial on the statins effects on serum IgG, IgA and IgM level in chronic hemodialysis patients in Bandarabbas

Full description

This study is a randomized controlled trial of statins effect on serum IgG, IgA and IgM level on chronic hemodialysis patients in Bandarabbas. The study is carried out in Hormozgan, Iran. Seventy four patient were randomized either to receive atorvastatin in addition of usual treatment or not. The primary outcomes were serum IgG,IgA and IgM level. The secondary outcome was drug side effects.

Enrollment: 74 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All chronic hemodialysis patients attending Shahid Mohammadi hospital during the study period
• Accepting to participate in the study

Exclusion criteria

• Refusing to participate in the study

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

74 participants in 1 patient group

lipitor

Experimental group

Description:

atorvastatin 20mg daily

Treatment:

Drug: Lipitor